Eli Lilly buying Loxo Oncology for about $8 billion

Save Story
Leer en español

Estimated read time: Less than a minute

This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.

STAMFORD, Conn. (AP) — Eli Lilly is buying Loxo Oncology for about $8 billion, broadening its lineup of cancer treatments.

Loxo Oncology Inc., based in Stamford, Connecticut, is a biopharmaceutical company focused on the development and commercialization of medicines for patients with genomically defined cancers.

Eli Lilly and Co. said Monday that it will pay $235 for each Loxo share. That's a 68 percent premium to the company's Friday closing price of $139.87.

The deal is expected to close by the end of the first quarter.

Shares of Eli Lilly, based in Indianapolis, fell 2.7 percent in Monday premarket trading.

Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Most recent Business stories

Related topics

The Associated Press


    Get informative articles and interesting stories delivered to your inbox weekly. Subscribe to the KSL.com Trending 5.
    By subscribing, you acknowledge and agree to KSL.com's Terms of Use and Privacy Policy.

    KSL Weather Forecast